The company said it would also get royalties and certain delayed payments on the product meeting some sales targets.
Bayer Schering will make unspecified upfront and milestone payments to ProStrakan as per the agreement, the company said.
(Reporting by Usman Merchant in Bangalore; Editing by Gopakumar Warrier) Keywords: PROSTRAKAN/ (usman.merchant@thomsonreuters.com; +44 207 542 7717;Reuters Messaging: usman.merchant@thomsonreuters.com)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
MMMM

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index